Clinical Trials Directory

Trials / Completed

CompletedNCT07043049

Comparison of Prophylactic Use of Tramadol Versus Ketamine for Prevention of Post Spinal Anesthesia Shivering

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Syed Muhammad Abbas · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to compare the effectiveness of tramadol versus ketamine in preventing shivering after spinal anesthesia in adult patients (ages 20-65) undergoing elective lower abdominal or inguinoscrotal surgeries. The main questions it aims to answer are: * Does prophylactic intravenous tramadol reduce the incidence and severity of shivering more effectively than ketamine after spinal anesthesia? * Are there differences in side effects, such as sedation or nausea, between tramadol and ketamine? Researchers will compare the tramadol group to the ketamine group to see which drug is more effective and safer for shivering prevention. Participants will: * Be randomly assigned to receive either tramadol (1 mg/kg) or ketamine (0.5 mg/kg) five minutes after spinal anesthesia. * Have their shivering severity assessed at 15, 30, 45, and 60 minutes using a standardized scale. * Be monitored for sedation, nausea, and other possible side effects.

Conditions

Interventions

TypeNameDescription
DRUGTramadolTramadol 1 mg/kg IV given 5 minutes after spinal anesthesia for prevention of post-anesthesia shivering
DRUGKetamineKetamine 0.5 mg/kg IV administered 5 minutes after spinal anesthesia for prevention of post-anesthesia shivering.

Timeline

Start date
2022-06-29
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2025-06-29
Last updated
2025-06-29

Locations

2 sites across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07043049. Inclusion in this directory is not an endorsement.